Recently/RB ,/, there/EX has/VBZ been/VBN a/DT resurgence/NN of/IN interest/NN in/IN rigorous/JJ algorithms/NNS for/IN the/DT inference/NN of/IN cancer/NN progression/NN from/IN genomic/JJ data/NNS ./.
The/DT motivations/NNS are/VBP manifold/JJ :/: (/-LRB- i/LS )/-RRB- growing/VBG NGS/NN and/CC single/JJ cell/NN data/NNS from/IN cancer/NN patients/NNS ,/, (/-LRB- ii/LS )/-RRB- need/VB for/IN novel/JJ Data/NNP Science/NNP and/CC Machine/NNP Learning/NNP algorithms/NNS to/TO infer/VB models/NNS of/IN cancer/NN progression/NN ,/, and/CC (/-LRB- iii/LS )/-RRB- a/DT desire/NN to/TO understand/VB the/DT temporal/JJ and/CC heterogeneous/JJ structure/NN of/IN tumor/NN to/IN tame/VB its/PRP$ progression/NN by/IN efficacious/JJ therapeutic/JJ intervention/NN ./.
This/DT thesis/NN presents/VBZ a/DT multi-disciplinary/JJ effort/NN to/TO model/VB tumor/NN progression/NN involving/VBG successive/JJ accumulation/NN of/IN genetic/JJ alterations/NNS ,/, each/DT resulting/VBG populations/NNS manifesting/VBG themselves/PRP in/IN a/DT cancer/NN phenotype/NN ./.
The/DT framework/NN presented/VBN in/IN this/DT work/NN along/IN with/IN algorithms/NNS derived/VBN from/IN it/PRP ,/, represents/VBZ a/DT novel/JJ approach/NN for/IN inferring/VBG cancer/NN progression/NN ,/, whose/WP$ accuracy/NN and/CC convergence/NN rates/NNS surpass/VBP the/DT existing/VBG techniques/NNS ./.
The/DT approach/NN derives/VBZ its/PRP$ power/NN from/IN several/JJ fields/NNS including/VBG algorithms/NNS in/IN machine/NN learning/NN ,/, theory/NN of/IN causality/NN and/CC cancer/NN biology/NN ./.
Furthermore/RB ,/, a/DT modular/JJ pipeline/NN to/TO extract/VB ensemble/NN -/HYPH level/NN progression/NN models/NNS from/IN sequenced/VBN cancer/NN genomes/NNS is/VBZ proposed/VBN ./.
The/DT pipeline/NN combines/VBZ state/NN -/HYPH of/IN -/HYPH the/DT -/HYPH art/NN techniques/NNS for/IN sample/NN stratification/NN ,/, driver/NN selection/NN ,/, identification/NN of/IN fitness/NN -/HYPH equivalent/JJ exclusive/JJ alterations/NNS and/CC progression/NN model/NN inference/NN ./.
Furthermore/RB ,/, the/DT results/NNS are/VBP validated/VBN by/IN synthetic/JJ data/NNS with/IN realistic/JJ generative/JJ models/NNS ,/, and/CC empirically/RB interpreted/VBN in/IN the/DT context/NN of/IN real/JJ cancer/NN datasets/NNS ;/: in/IN the/DT later/JJ case/NN ,/, biologically/RB significant/JJ conclusions/NNS are/VBP also/RB highlighted/VBN ./.
Specifically/RB ,/, it/PRP demonstrates/VBZ the/DT pipeline/NN 's/POS ability/NN to/TO reproduce/VB much/RB of/IN the/DT knowledge/NN on/IN colorectal/JJ cancer/NN ,/, as/RB well/RB as/IN to/TO suggest/VB novel/JJ hypotheses/NNS ./.
Lastly/RB ,/, it/PRP also/RB proves/VBZ that/IN the/DT proposed/VBN framework/NN can/MD be/VB applied/VBN to/TO reconstruct/VB the/DT evolutionary/JJ history/NN of/IN cancer/NN clones/NNS in/IN single/JJ patients/NNS ,/, as/IN illustrated/VBN by/IN an/DT example/NN from/IN clear/JJ cell/NN renal/JJ carcinomas/NNS ./.
